(Q39430176)

11 September 2017

1 reference

title

Strategies for prevention of transfusion-associated Chagas' disease (English)

1 reference

11 September 2017

0 references

Moraes-Souza H

1

1 reference

11 September 2017

Bordin JO

series ordinal

2

1 reference

11 September 2017

publication date

1 July 1996

1 reference

Transfusion Medicine Reviews

11 September 2017

published in

1 reference

11 September 2017

volume

10

1 reference

11 September 2017

issue

3

1 reference

11 September 2017

page(s)

161-170

1 reference

Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

American trypanosomiasis (Chagas' disease)--a tropical disease now in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Transfusion-associated acute Chagas disease acquired in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Transfusion-associated Trypanosoma cruzi infection in a non-endemic area

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Acute Chagas' disease in a recipient of a bone marrow transplant in Spain: case report

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Angiographic and electrophysiologic substrates of ventricular tachycardia in chronic Chagasic myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Control of Chagas disease in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Chagas' heart disease in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Is Trypanosoma cruzi a new threat to our blood supply?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

1 reference

7 January 2021

Use of a questionnaire to identify potential blood donors at risk for infection with Trypanosoma cruzi.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

1 reference

7 January 2021

[Hemoculture: sensitive technique in the detection of Trypanosoma cruzi in chagasic patients in the chronic phase of Chagas disease]

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Absence of serological surrogate markers for Trypanosoma-cruzi-infected blood donors.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

[Serological survey of the prevalence of Chagas' infection in Brazil, 1975/1980]

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Microplate enzyme-linked immunosorbent assay for chagas' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Chagas' disease diagnosis: evaluation of several tests in blood bank screening

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. I. Evaluation of the sensitivity and specificity of an enzyme immunoassay for detecting antibodies to T. cruzi

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Chagas' disease: serodiagnosis with purified Gp25 antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Increased specificity of serodiagnosis of Chagas' disease by detection of antibody to the 72- and 90-kilodalton glycoproteins of Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. II. Evaluation of a supplemental enzyme immunoassay and radioimmunoprecipitation assay for confirmation of seroreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Immune precipitation and immunoblotting for the detection of Trypanosoma cruzi antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

IgG antibody reactivity with Trypanosoma cruzi and Leishmania antigens in sera of patients with Chagas' disease and leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Polymerase chain reaction-based detection of Trypanosoma cruzi DNA in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Prevalence of antibody to Trypanosoma cruzi among blood donors in Los Angeles, California

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Light-Enhanced Free Radical Formation and Trypanocidal Action of Gentian Violet (Crystal Violet)

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

The metabolism and mode of action of gentian violet

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Prevention of transfusion-associated Chagas' disease by sterilization of Trypanosoma cruzi-infected blood with gentian violet, ascorbic acid, and light

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Enhancement of the cytotoxicity of crystal violet against Trypanosoma cruzi in the blood by ascorbate

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

The use of crystal violet in the prevention of the transfusional transmission of Chagas-Mazza disease (South American trypanosomiasis).

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Cryopreservation ofTrypanosoma cruziBloodstream Forms*

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

The role of leukodepletion in the control of transfusion-transmitted disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

Prevention of transfusion-associated Chagas' disease: efficacy of white cell-reduction filters in removing Trypanosoma cruzi from infected blood

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980057-5

7 January 2021

10.1016/S0887-7963(96)80057-5

Identifiers

DOI

1 reference

11 September 2017

1 reference